[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | ||
England and Wales High Court (Chancery Division) Decisions |
||
You are here: BAILII >> Databases >> England and Wales High Court (Chancery Division) Decisions >> Amerisur Resources Plc, Re Companies Act 2006 [2020] EWHC 315 (Ch) (14 January 2020) URL: http://www.bailii.org/ew/cases/EWHC/Ch/2020/315.html Cite as: [2020] EWHC 315 (Ch) |
[New search] [Printable PDF version] [Help]
BUSINESS AND PROPERTY COURTS OF ENGLAND AND WALES
COMPANIES LIST (ChD)
Fetter Lane London EC4A 1NL |
||
B e f o r e :
____________________
IN THE MATTER OF AMERISUR RESOURCES PLC | ||
AND IN THE MATTER OF THE COMPANIES ACT 2006 |
____________________
Lower Ground, 18-22 Furnival Street, London, EC4A 1JS
Tel No: 020 7404 1400
Web: www.epiqglobal.com/en-gb/ Email: [email protected]
(Official Shorthand Writers to the Court)
____________________
Crown Copyright ©
MR JUSTICE ZACAROLI:
"The second argument raised by Mr Richards, counsel for the company, arguing that the objectors lacked standing, is that it is not so much the scheme of arrangement but the subsequent dividend in specie whereby the company transfers BAX and Farmers to BAT Reconstructions to which the objectors really object. That is plainly right. The scheme of arrangement as such in no way deprives the company of any assets. Mr Richards rightly points out that the dividend in specie is not part of the scheme of arrangement but a subsequent step which the company, acting by its board of directors, intends to take. To my mind the fact that the objectors object to a consequence of the scheme does not prevent them from being heard and does not at any rate without more prevent them having their interests taken into account. If it is permissible in an appropriate case to take into account third party concerns when considering whether to sanction a scheme, it seems to me unduly artificial if one can take them into account if they are affected by the scheme itself, but not if they are affected by a subsequent step which is clearly dependent on and consequent on the sanction and implementation of the scheme. The court can scarcely be expected to sanction the scheme unless it appreciates its full commercial and factual context. If that is correct, then it seems to me to follow that one could take into account subsequent steps also for the purposes of considering third party objections. Accordingly it does appear to me that, as a matter of principle, the court can take into account the concerns of the objectors even though they are not the company or members of the company and one can take them into account even though their concerns arise not from the scheme itself but from the steps which will inevitably follow if and when the scheme is implemented."
"Save as set out in respect of the review and their issuer's locations of business in this section, GeoPark [the purchasing group] has no intention to redeploy any of the fixed assets of the Amerisur group."
"First, this is a matter where the court's primary concern under s.425 is between the Company and its members. I accept that the primary purpose of the court sanctioning a scheme under s.425(2) is to bind all the members of the Company. I also bear in mind the principle stated in Buckley and the absence of any provision in section 425 equivalent to s.136(3). Insofar as the scheme requires consent under s. 137, the reduction of capital will immediately be followed by a capitalisation so that there will be no net reduction of capital in the scheme for which the approval of the court is sought. That cannot be objected to by the objectors.
Secondly, it is not the scheme to which objection is taken by the objectors but a step which will be taken once the scheme is approved, namely the dividend in specie.
Thirdly, the scheme is not, as a matter of logic or law, a necessary precondition for the dividend in specie. Such a distribution could, at least in principle, be made without any scheme.
Fourthly, there is nothing in the documentation, which is fairly voluminous, to suggest that the purpose of the scheme, or even one of the purposes of the scheme, or of the making of the dividend in specie, is to deprive the objectors, or any other actual or potential plaintiff, of monies which they might otherwise be able to recover following any judgments that they obtain against the Company in U.S. tobacco litigation …
Fifthly, the legislature has set out in Part VIII of the 1985 Act the requirements which have to be satisfied before a distribution, such as the dividend in specie in the present case, can be made. Those requirements do not include the sanction of the court. It is only because of the happenstance of the scheme requiring the court's sanction under s.425 and s.137 that the issue of the dividend in specie can be raised by the objectors in court at all.
Sixthly, the directors have formed a view that the dividend in specie can be made. That view is not challenged as being dishonest, and cannot on the evidence I have seen be challenged as being unreasonable …
Seventhly, the objectors would have no right to come to court in the absence of this scheme to object to the making of the dividend in specie per se unless they could show that it was part of some sort of process calculated to dispossess them of the potential fruits of the U.S. tobacco proceedings …
Eighthly, the objectors have no present enforceable claims against the Company. They only have potential claims which depend on establishing jurisdiction, liability in law and liability on the facts in the United States against the Company …
Ninthly, in recommending the overall proposals to shareholders and in preparing the interim accounts and deciding to make a dividend in specie, the board has been (and will be) required carefully to consider the financial position of the Company having regard to all relevant factors including the U.S. tobacco litigation. The directors have needed to be satisfied that the Company is legally and financially in a position to pay the dividend in specie, and thereafter to carry on business following the demerger of the net assets of the Company having regard to an actual asset value which will, as I have mentioned, be some £6.5 billion."
Neuberger J went on to sanction the scheme in that case.
Epiq Europe Ltd hereby certify that the above is an accurate and complete record of the proceedings or part thereof.
Lower Ground, 18-22 Furnival Street, London EC4A 1JS
Tel No: 020 7404 1400
Email: [email protected]